{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:11:48Z","timestamp":1793067108037,"version":"4.5.0"},"reference-count":188,"publisher":"Informa UK Limited","issue":"10","funder":[{"name":"Taylor\u2019s University Flagship Research Grant","award":["TUFR\/2017\/002\/04"],"award-info":[{"award-number":["TUFR\/2017\/002\/04"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Neuroscience"],"published-print":{"date-parts":[[2023,10,3]]},"DOI":"10.1080\/00207454.2022.2045290","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T07:23:45Z","timestamp":1647242625000},"page":"1071-1089","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["A reappraisal on amyloid cascade hypothesis: the role of chronic infection in Alzheimer\u2019s disease"],"prefix":"10.1080","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-8706","authenticated-orcid":false,"given":"Zhi Xin","family":"Phuna","sequence":"first","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences, Taylor\u2019s University, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6714-1279","authenticated-orcid":false,"given":"Priya","family":"Madhavan","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences, Taylor\u2019s University, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"issue":"8","key":"e_1_3_5_2_1","first-page":"a006239","article-title":"Epidemiology of Alzheimer disease","volume":"2","author":"Mayeux R","year":"2012","unstructured":"Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med 2. 2012;2(8):a006239.","journal-title":"Cold Spring Harb Perspect Med 2"},{"issue":"4","key":"e_1_3_5_3_1","first-page":"581","article-title":"Pathogenesis of Alzheimer\u2019s disease: role of amyloid-beta and hyperphosphorylated tau protein","volume":"80","author":"Sajjad R","year":"2018","unstructured":"Sajjad R, Arif R, Shah AA, et\u00a0al. Pathogenesis of Alzheimer\u2019s disease: role of amyloid-beta and hyperphosphorylated tau protein. Pharm. Sci. 2018;80(4):581\u2013591.","journal-title":"Pharm. Sci"},{"issue":"1","key":"e_1_3_5_4_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000464422","article-title":"Molecular pathogenesis of Alzheimer\u2019s disease: an update","volume":"24","author":"Sanabria-Castro A","year":"2017","unstructured":"Sanabria-Castro A, Alvarado-Echeverr\u00eda I, Monge-Bonilla C. Molecular pathogenesis of Alzheimer\u2019s disease: an update. Ann Neurosci. 2017;24(1):46\u201354.","journal-title":"Ann Neurosci"},{"issue":"8","key":"e_1_3_5_5_1","doi-asserted-by":"crossref","first-page":"e015746","DOI":"10.1136\/bmjopen-2016-015746","article-title":"Signs and symptoms preceding the diagnosis of Alzheimer\u2019s disease: a systematic scoping review of literature from 1937 to 2016","volume":"7","author":"Bature F","year":"2017","unstructured":"Bature F, Guinn B-A, Pang D, et\u00a0al. Signs and symptoms preceding the diagnosis of Alzheimer\u2019s disease: a systematic scoping review of literature from 1937 to 2016. BMJ Open. 2017;7(8):e015746.","journal-title":"BMJ Open"},{"issue":"9","key":"e_1_3_5_6_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11910-018-0863-1","article-title":"Viral hypothesis and antiviral treatment in Alzheimer\u2019s disease","volume":"18","author":"Devanand DP.","year":"2018","unstructured":"Devanand DP. Viral hypothesis and antiviral treatment in Alzheimer\u2019s disease. Curr Neurol Neurosci Rep. 2018;18(9):55.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"e_1_3_5_7_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-05903-y","article-title":"Polymicrobial infections in brain tissue from Alzheimer\u2019s disease patients","volume":"7","author":"Pisa D","year":"2017","unstructured":"Pisa D, Alonso R, Fern\u00e1ndez-Fern\u00e1ndez AM, et\u00a0al. Polymicrobial infections in brain tissue from Alzheimer\u2019s disease patients. Sci Rep. 2017;7(1):5559.","journal-title":"Sci Rep"},{"key":"e_1_3_5_8_1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fnagi.2018.00224","article-title":"Can an infection hypothesis explain the beta amyloid hypothesis of Alzheimer\u2019s Disease?","volume":"10","author":"Fulop T","year":"2018","unstructured":"Fulop T, Witkowski JM, Bourgade K, et\u00a0al. Can an infection hypothesis explain the beta amyloid hypothesis of Alzheimer\u2019s Disease? Front Aging Neurosci. 2018;10:224.","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"e_1_3_5_9_1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2174\/1567205014666170316163340","article-title":"Association between periodontal health status and cognitive abilities. The role of cytokine profile and systemic inflammation","volume":"14","author":"Sochocka M","year":"2017","unstructured":"Sochocka M, Sobczy\u0144ski M, Sender-Janeczek A, et\u00a0al. Association between periodontal health status and cognitive abilities. The role of cytokine profile and systemic inflammation. CAR. 2017;14(9):978\u2013990.","journal-title":"CAR"},{"issue":"1","key":"e_1_3_5_10_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9758\/cpn.2017.15.1.1","article-title":"Mechanisms of Alzheimer\u2019s disease pathogenesis and prevention: the brain, neural pathology, n-methyl-d-aspartate receptors, tau protein and other risk factors","volume":"15","author":"Kocahan S","year":"2017","unstructured":"Kocahan S, Do\u011fan Z . Mechanisms of Alzheimer\u2019s disease pathogenesis and prevention: the brain, neural pathology, n-methyl-d-aspartate receptors, tau protein and other risk factors. Clin Psychopharmacol Neurosci. 2017;15(1):1\u20138.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"1","key":"e_1_3_5_11_1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5056\/jnm18087","article-title":"Brain-gut-microbiota axis in Alzheimer\u2019s disease","volume":"25","author":"Kowalski K","year":"2019","unstructured":"Kowalski K, Mulak A. Brain-gut-microbiota axis in Alzheimer\u2019s disease. J Neurogastroenterol Motil. 2019;25(1):48\u201360.","journal-title":"J Neurogastroenterol Motil"},{"issue":"5","key":"e_1_3_5_12_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/archdischild-2016-311643","article-title":"What is the microbiome?","volume":"102","author":"Amon P","year":"2017","unstructured":"Amon P, Sanderson I. What is the microbiome? Arch Dis Child Educ Pract Ed. 2017;102(5):257\u2013260.","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"1","key":"e_1_3_5_13_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-161141","article-title":"The gut microbiota and Alzheimer\u2019s disease","volume":"58","author":"Jiang C","year":"2017","unstructured":"Jiang C, Li G, Huang P, et\u00a0al. The gut microbiota and Alzheimer\u2019s disease. J Alzheimers Dis. 2017;58(1):1\u201315.","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"e_1_3_5_14_1","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: hopes, threats and promises","volume":"67","author":"Cani PD.","year":"2018","unstructured":"Cani PD. Human gut microbiome: hopes, threats and promises. Gut. 2018;67(9):1716\u20131725.","journal-title":"Gut"},{"issue":"2","key":"e_1_3_5_15_1","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, Central and enteric nervous systems","volume":"28","author":"Carabotti M","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, et\u00a0al. The gut-brain axis: interactions between enteric microbiota, Central and enteric nervous systems. Ann Gastroenterol. 2015;28(2):203\u2013209.","journal-title":"Ann Gastroenterol"},{"issue":"38","key":"e_1_3_5_16_1","doi-asserted-by":"crossref","first-page":"16050","DOI":"10.1073\/pnas.1102999108","article-title":"Ingestion of lactobacillus strain regulates emotional behavior and Central GABA receptor expression in a mouse via the vagus nerve","volume":"108","author":"Bravo JA","year":"2011","unstructured":"Bravo JA, Forsythe P, Chew MV, et\u00a0al. Ingestion of lactobacillus strain regulates emotional behavior and Central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050\u201316055.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"e_1_3_5_17_1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny D","year":"2015","unstructured":"Erny D, Hrab\u011b de Angelis AL, Jaitin D, et\u00a0al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18(7):965\u2013977.","journal-title":"Nat Neurosci"},{"issue":"5","key":"e_1_3_5_18_1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cmet.2014.07.003","article-title":"Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates","volume":"20","author":"Sonnenburg ED","year":"2014","unstructured":"Sonnenburg ED, Sonnenburg JL. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab. 2014;20(5):779\u2013786.","journal-title":"Cell Metab"},{"issue":"1","key":"e_1_3_5_19_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12974-020-01760-1","article-title":"Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice","volume":"17","author":"Shi H","year":"2020","unstructured":"Shi H, Wang Q, Zheng M, et\u00a0al. Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice. J Neuroinflammation. 2020;17(1):77.","journal-title":"J Neuroinflammation"},{"key":"e_1_3_5_20_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fnins.2018.00049","article-title":"The vagus nerve at the interface of the Microbiota-Gut-Brain axis","volume":"12","author":"Bonaz B","year":"2018","unstructured":"Bonaz B, Bazin T, Pellissier S. The vagus nerve at the interface of the Microbiota-Gut-Brain axis. Front Neurosci. 2018;12:49.","journal-title":"Front Neurosci"},{"issue":"1","key":"e_1_3_5_21_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13311-017-0600-5","article-title":"Gut microbiota and the neuroendocrine system","volume":"15","author":"Farzi A","year":"2018","unstructured":"Farzi A, Fr\u00f6hlich EE, Holzer P. Gut microbiota and the neuroendocrine system. Neurotherapeutics. 2018;15(1):5\u201322.","journal-title":"Neurotherapeutics"},{"key":"e_1_3_5_22_1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fnagi.2018.00159","article-title":"Infection of fungi and bacteria in brain tissue from elderly persons and patients with Alzheimer\u2019s Disease","volume":"10","author":"Alonso R","year":"2018","unstructured":"Alonso R, Pisa D, Fern\u00e1ndez-Fern\u00e1ndez AM, et\u00a0al. Infection of fungi and bacteria in brain tissue from elderly persons and patients with Alzheimer\u2019s Disease. Front Aging Neurosci. 2018;10:159.","journal-title":"Front Aging Neurosci"},{"issue":"263","key":"e_1_3_5_23_1","doi-asserted-by":"crossref","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice","volume":"6","author":"Braniste V","year":"2014","unstructured":"Braniste V, Al-Asmakh M, Kowal C, et\u00a0al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6(263):263ra158.","journal-title":"Sci Transl Med"},{"issue":"1","key":"e_1_3_5_24_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-160884","article-title":"Alzheimer\u2019s disease histological and\u00a0behavioral manifestations in transgenic mice correlate with specific gut microbiome state","volume":"56","author":"Shen L","year":"2017","unstructured":"Shen L, Liu L, Ji H-F . Alzheimer\u2019s disease histological and\u00a0behavioral manifestations in transgenic mice correlate with specific gut microbiome state. J Alzheimers Dis. 2017;56(1):385\u2013390.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"e_1_3_5_25_1","article-title":"Gut microbiome alterations in Alzheimer\u2019s disease","volume":"7","author":"Vogt NM","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, et\u00a0al. Gut microbiome alterations in Alzheimer\u2019s disease. Sci Rep. 2017;7(1):13537.","journal-title":"Sci Rep"},{"issue":"1","key":"e_1_3_5_26_1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41467-017-00040-6","article-title":"Intestinal microbial dysbiosis aggravates the progression of Alzheimer\u2019s disease in Drosophila","volume":"8","author":"Wu S-C","year":"2017","unstructured":"Wu S-C, Cao Z-S, Chang K-M, et\u00a0al . Intestinal microbial dysbiosis aggravates the progression of Alzheimer\u2019s disease in Drosophila. Nat Commun. 2017;8(1):24.","journal-title":"Nat Commun"},{"key":"e_1_3_5_27_1","doi-asserted-by":"crossref","first-page":"eaba0466","DOI":"10.1126\/sciadv.aba0466","article-title":"Gut dysbiosis contributes to amyloid pathology, associated with C\/EBP\u03b2\/AEP signaling activation in Alzheimer\u2019s disease mouse model","volume":"6","author":"Chen C","year":"2020","unstructured":"Chen C, Ahn EH, Kang SS, et\u00a0al. Gut dysbiosis contributes to amyloid pathology, associated with C\/EBP\u03b2\/AEP signaling activation in Alzheimer\u2019s disease mouse model. Sci Adv. 2020;6:eaba0466.","journal-title":"Sci Adv"},{"issue":"2","key":"e_1_3_5_28_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","article-title":"Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model","volume":"69","author":"Kim M-S","year":"2020","unstructured":"Kim M-S, Kim Y, Choi H, et\u00a0al . Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut. 2020;69(2):283\u2013294.","journal-title":"Gut"},{"issue":"4","key":"e_1_3_5_29_1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/CMR.00118-13","article-title":"Pathogens penetrating the Central nervous system: infection pathways and the cellular and molecular mechanisms of invasion","volume":"27","author":"Dando SJ","year":"2014","unstructured":"Dando SJ, Mackay-Sim A, Norton R, et\u00a0al. Pathogens penetrating the Central nervous system: infection pathways and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev. 2014;27(4):691\u2013726.","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"e_1_3_5_30_1","doi-asserted-by":"crossref","first-page":"e1006680","DOI":"10.1371\/journal.ppat.1006680","article-title":"False friends: phagocytes as trojan horses in microbial brain infections","volume":"13","author":"Santiago-Tirado FH","year":"2017","unstructured":"Santiago-Tirado FH, Doering TL. False friends: phagocytes as trojan horses in microbial brain infections. PLoS Pathog. 2017;13(12):e1006680.","journal-title":"PLoS Pathog"},{"key":"e_1_3_5_31_1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-015-0434-1","article-title":"Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit","volume":"12","author":"Banks WA","year":"2015","unstructured":"Banks WA, Gray AM, Erickson MA, et\u00a0al. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflammation. 2015;12:223.","journal-title":"J Neuroinflammation"},{"issue":"340","key":"e_1_3_5_32_1","first-page":"340ra72","article-title":"Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease","volume":"8","author":"Kumar DKV","year":"2016","unstructured":"Kumar DKV, Choi SH, Washicosky KJ, et\u00a0al . Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease. Sci Transl Med. 2016;8(340):340ra72.","journal-title":"Sci Transl Med"},{"issue":"7","key":"e_1_3_5_33_1","doi-asserted-by":"crossref","first-page":"e101364","DOI":"10.1371\/journal.pone.0101364","article-title":"Alzheimer\u2019s associated \u03b2-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes","volume":"9","author":"White MR","year":"2014","unstructured":"White MR, Kandel R, Tripathi S, et\u00a0al . Alzheimer\u2019s associated \u03b2-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS One. 2014;9(7):e101364.","journal-title":"PLoS One"},{"issue":"19","key":"e_1_3_5_34_1","doi-asserted-by":"crossref","first-page":"eaay8828","DOI":"10.1126\/sciadv.aay8828","article-title":"A 3D human brain-like tissue model of herpes-induced Alzheimer\u2019s disease","volume":"6","author":"Cairns DM","year":"2020","unstructured":"Cairns DM, Rouleau N, Parker RN, et\u00a0al. A 3D human brain-like tissue model of herpes-induced Alzheimer\u2019s disease. Sci Adv. 2020;6(19):eaay8828.","journal-title":"Sci Adv"},{"key":"e_1_3_5_35_1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnagi.2016.00160","article-title":"Mechanisms of A\u03b2 clearance and degradation by glial cells","volume":"8","author":"Ries M","year":"2016","unstructured":"Ries M, Sastre M. Mechanisms of A\u03b2 clearance and degradation by glial cells. Front Aging Neurosci. 2016;8:160.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"e_1_3_5_36_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-018-0247-7","article-title":"Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)","volume":"13","author":"Zhong L","year":"2018","unstructured":"Zhong L, Wang Z, Wang D, et\u00a0al. Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2). Mol Neurodegener. 2018;13(1):15.","journal-title":"Mol Neurodegener"},{"key":"e_1_3_5_37_1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fnmol.2017.00427","article-title":"Involvement of astrocytes in Alzheimer\u2019s disease from a neuroinflammatory and oxidative stress perspective","volume":"10","author":"Gonz\u00e1lez-Reyes RE","year":"2017","unstructured":"Gonz\u00e1lez-Reyes RE, Nava-Mesa MO, Vargas-S\u00e1nchez K, et\u00a0al. Involvement of astrocytes in Alzheimer\u2019s disease from a neuroinflammatory and oxidative stress perspective. Front Mol Neurosci. 2017;10:427.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"e_1_3_5_38_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.0902-0055.2001.00100.x","article-title":"Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer\u2019s disease","volume":"17","author":"Riviere GR","year":"2002","unstructured":"Riviere GR, Riviere KH, Smith KS. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer\u2019s disease. Oral Microbiol. Immunol. 2002;17(2):113\u2013118.","journal-title":"Oral Microbiol. Immunol"},{"issue":"1","key":"e_1_3_5_39_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0047-6374(88)90058-9","article-title":"Alzheimer\u2019s disease: an olfactory connection?","volume":"42","author":"Mann DMA","year":"1988","unstructured":"Mann DMA, Tucker CM, Yates PO. Alzheimer\u2019s disease: an olfactory connection? Mech Ageing Dev. 1988;42(1):1\u201315.","journal-title":"Mech Ageing Dev"},{"issue":"17","key":"e_1_3_5_40_1","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1007\/s00018-008-8184-1","article-title":"Olfactory ensheathing cells are attracted to, and can endocytose, bacteria","volume":"65","author":"Leung JYK","year":"2008","unstructured":"Leung JYK, Chapman JA, Harris JA, et\u00a0al. Olfactory ensheathing cells are attracted to, and can endocytose, bacteria. Cell Mol Life Sci. 2008;65(17):2732\u20132739.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"e_1_3_5_41_1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jps.23836","article-title":"Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake","volume":"103","author":"Musumeci T","year":"2014","unstructured":"Musumeci T, Pellitteri R, Spatuzza M, et\u00a0al. Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake. J Pharm Sci. 2014;103(2):628\u2013635.","journal-title":"J Pharm Sci"},{"issue":"3","key":"e_1_3_5_42_1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/JAD-141170","article-title":"The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer\u2019s disease","volume":"43","author":"Shoemark DK","year":"2015","unstructured":"Shoemark DK, Allen SJ. The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer\u2019s disease. J Alzheimers Dis. 2015;43(3):725\u2013738.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"e_1_3_5_43_1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13195-017-0282-6","article-title":"Association between chronic periodontitis and the risk of Alzheimer\u2019s disease: a retrospective, population-based, matched-cohort study","volume":"9","author":"Chen C-K","year":"2017","unstructured":"Chen C-K, Wu Y-T, Chang Y-C . Association between chronic periodontitis and the risk of Alzheimer\u2019s disease: a retrospective, population-based, matched-cohort study. Alzheimers Res Ther. 2017;9(1):56.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"e_1_3_5_44_1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000449166","article-title":"Are chronic periodontitis and gingivitis associated with dementia? A nationwide, retrospective, Matched-Cohort study in Taiwan","volume":"47","author":"Tzeng N-S","year":"2016","unstructured":"Tzeng N-S, Chung C-H, Yeh C-B, et\u00a0al. Are chronic periodontitis and gingivitis associated with dementia? A nationwide, retrospective, Matched-Cohort study in Taiwan. Neuroepidemiology. 2016;47(2):82\u201393.","journal-title":"Neuroepidemiology"},{"key":"e_1_3_5_45_1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fnagi.2018.00415","article-title":"Tooth loss is associated with increased risk of dementia and with a Dose-Response Relationship","volume":"10","author":"Chen J","year":"2018","unstructured":"Chen J, Ren C-J, Wu L, et\u00a0al. Tooth loss is associated with increased risk of dementia and with a Dose-Response Relationship. Front Aging Neurosci. 2018;10:415.","journal-title":"Front Aging Neurosci"},{"key":"e_1_3_5_46_1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fneur.2019.00323","article-title":"Association between periodontitis and cognitive impairment in adults: a systematic review","volume":"10","author":"Nascimento PC","year":"2019","unstructured":"Nascimento PC, Castro MML, Magno MB, et\u00a0al. Association between periodontitis and cognitive impairment in adults: a systematic review. Front Neurol. 2019;10:323.","journal-title":"Front Neurol"},{"issue":"1","key":"e_1_3_5_47_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1902\/annals.1999.4.1.32","article-title":"Periodontitis","volume":"4","author":"Flemmig TF.","year":"1999","unstructured":"Flemmig TF. Periodontitis. Ann Periodontol. 1999;4(1):32\u201338.","journal-title":"Ann Periodontol"},{"issue":"10","key":"e_1_3_5_48_1","doi-asserted-by":"crossref","first-page":"e0204941","DOI":"10.1371\/journal.pone.0204941","article-title":"Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice","volume":"13","author":"Ilievski V","year":"2018","unstructured":"Ilievski V, Zuchowska PK, Green SJ, et\u00a0al. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice. PLoS One. 2018;13(10):e0204941.","journal-title":"PLoS One"},{"key":"e_1_3_5_49_1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3389\/fnins.2020.00658","article-title":"Periodontitis induced by P. gingivalis-LPS is associated with neuroinflammation and learning and memory impairment in Sprague-Dawley rats","volume":"14","author":"Hu Y","year":"2020","unstructured":"Hu Y, Li H, Zhang J, et\u00a0al. Periodontitis induced by P. gingivalis-LPS is associated with neuroinflammation and learning and memory impairment in Sprague-Dawley rats. Front Neurosci. 2020;14:658.","journal-title":"Front Neurosci"},{"issue":"1","key":"e_1_3_5_50_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12974-017-1052-x","article-title":"Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL\/6 mice","volume":"15","author":"Zhang J","year":"2018","unstructured":"Zhang J, Yu C, Zhang X, et\u00a0al. Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL\/6 mice. J Neuroinflammation. 2018;15(1):37.","journal-title":"J Neuroinflammation"},{"key":"e_1_3_5_51_1","first-page":"e12172","article-title":"Periodontal dysbiosis associates with reduced CSF A\u03b242 in cognitively normal elderly","volume":"13","author":"Kamer AR","year":"2021","unstructured":"Kamer AR, Pushalkar S, Gulivindala D, et\u00a0al. 2021. Periodontal dysbiosis associates with reduced CSF A\u03b242 in cognitively normal elderly. Alzheimer\u2019s Dement. 13:e12172.","journal-title":"Alzheimer\u2019s Dement"},{"key":"e_1_3_5_52_1","doi-asserted-by":"crossref","first-page":"633735","DOI":"10.3389\/fncel.2021.633735","article-title":"The oral-gut-brain AXIS: the influence of microbes in Alzheimer\u2019s disease","volume":"15","author":"Narengaowa Kong W","year":"2021","unstructured":"Narengaowa Kong W, Lan F, Awan UF, et\u00a0al. The oral-gut-brain AXIS: the influence of microbes in Alzheimer\u2019s disease. Front. Cell. Neurosci. 2021;15:633735.","journal-title":"Front. Cell. Neurosci"},{"issue":"3","key":"e_1_3_5_53_1","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftaa024","article-title":"Oral bacteria affect the gut microbiome and intestinal immunity","volume":"78","author":"Kobayashi R","year":"2020","unstructured":"Kobayashi R, Ogawa Y, Hashizume-Takizawa T, et\u00a0al. Oral bacteria affect the gut microbiome and intestinal immunity. Pathog Dis. 2020;78(3):ftaa024.","journal-title":"Pathog Dis"},{"issue":"1","key":"e_1_3_5_54_1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12974-020-02027-5","article-title":"Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice","volume":"17","author":"Feng Y-K","year":"2020","unstructured":"Feng Y-K, Wu Q-L, Peng Y-W, et\u00a0al. Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice. J Neuroinflammation. 2020;17(1):347.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"e_1_3_5_55_1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrmicro2747","article-title":"The structural biology of HIV-1: mechanistic and therapeutic insights","volume":"10","author":"Engelman A","year":"2012","unstructured":"Engelman A, Cherepanov P. The structural biology of HIV-1: mechanistic and therapeutic insights. Nat Rev Microbiol. 2012;10(4):279\u2013290.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"e_1_3_5_56_1","doi-asserted-by":"crossref","first-page":"a007096","DOI":"10.1101\/cshperspect.a007096","article-title":"HIV latency","volume":"1","author":"Siliciano RF","year":"2011","unstructured":"Siliciano RF, Greene WC. HIV latency. Cold Spring Harb Perspect Med. 2011;1(1):a007096.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"e_1_3_5_57_1","first-page":"e515","article-title":"Current scenario of HIV\/AIDS, treatment options, and major challenges with compliance to antiretroviral Therapy","volume":"8","author":"Bhatti AB","year":"2016","unstructured":"Bhatti AB, Usman M, Kandi V. Current scenario of HIV\/AIDS, treatment options, and major challenges with compliance to antiretroviral Therapy. Cureus. 2016;8(3):e515.","journal-title":"Cureus"},{"issue":"2","key":"e_1_3_5_58_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.sbi.2008.02.001","article-title":"The structural biology of HIV assembly","volume":"18","author":"Ganser-Pornillos BK","year":"2008","unstructured":"Ganser-Pornillos BK, Yeager M, Sundquist WI. The structural biology of HIV assembly. Curr Opin Struct Biol. 2008;18(2):203\u2013217.","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"e_1_3_5_59_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jmbi.1998.2354","article-title":"Structural biology of HIV","volume":"285","author":"Turner BG","year":"1999","unstructured":"Turner BG, Summers MF. Structural biology of HIV. J Mol Biol. 1999;285(1):1\u201332.","journal-title":"J Mol Biol"},{"issue":"4","key":"e_1_3_5_60_1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder-pathogenesis and prospects for treatment","volume":"12","author":"Saylor D","year":"2016","unstructured":"Saylor D, Dickens AM, Sacktor N, et\u00a0al. HIV-associated neurocognitive disorder-pathogenesis and prospects for treatment. Nat Rev Neurol. 2016;12(4):234\u2013248.","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"e_1_3_5_61_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/brainsci7040038","article-title":"The role of HIV infection in neurologic injury","volume":"7","author":"Scutari R","year":"2017","unstructured":"Scutari R, Alteri C, Perno C, et\u00a0al. The role of HIV infection in neurologic injury. Brain Sci. 2017;7(12):38.","journal-title":"Brain Sci"},{"issue":"18","key":"e_1_3_5_62_1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori A","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, et\u00a0al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789\u20131799.","journal-title":"Neurology"},{"issue":"2","key":"e_1_3_5_63_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jis326","article-title":"Central nervous system viral invasion and inflammation during acute HIV infection","volume":"206","author":"Valcour V","year":"2012","unstructured":"Valcour V, Chalermchai T, Sailasuta N, RV254\/SEARCH 010 Study Group, et\u00a0al. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis. 2012;206(2):275\u2013282.","journal-title":"J Infect Dis"},{"issue":"2","key":"e_1_3_5_64_1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1189\/jlb.5A0714-347R","article-title":"JAM-A AND ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals","volume":"97","author":"Williams DW","year":"2015","unstructured":"Williams DW, Anastos K, Morgello S, et al. JAM-A AND ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol. 2015;97(2):401\u2013412.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"e_1_3_5_65_1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1189\/jlb.0811394","article-title":"Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis","volume":"91","author":"Williams DW","year":"2012","unstructured":"Williams DW, Eugenin EA, Calderon TM, et al. Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol. 2012;91(3):401\u2013415.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"e_1_3_5_66_1","doi-asserted-by":"crossref","first-page":"e01280","DOI":"10.1128\/mBio.01280-17","article-title":"Mechanisms of CNS viral seeding by HIV\u2009+\u2009CD14+ CD16+ monocytes: establishment and reseeding of viral reservoirs contributing to HIV-Associated neurocognitive disorders","volume":"8","author":"Veenstra M","year":"2017","unstructured":"Veenstra M, Le\u00f3n-Rivera R, Li M, et\u00a0al. Mechanisms of CNS viral seeding by HIV\u2009+\u2009CD14+ CD16+ monocytes: establishment and reseeding of viral reservoirs contributing to HIV-Associated neurocognitive disorders. mBio. 2017a;8(5):e01280\u201317.","journal-title":"mBio"},{"issue":"5","key":"e_1_3_5_67_1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1189\/jlb.3HI0517-167R","article-title":"Frontline science: CXCR7 mediates CD14\u2009+\u2009CD16+ monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS","volume":"102","author":"Veenstra M","year":"2017","unstructured":"Veenstra M, Williams DW, Calderon TM, et\u00a0al. Frontline science: CXCR7 mediates CD14\u2009+\u2009CD16+ monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS. J Leukoc Biol. 2017b;102(5):1173\u20131185.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"e_1_3_5_68_1","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1212\/NXI.0000000000000036","article-title":"CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders","volume":"1","author":"Williams DW","year":"2014","unstructured":"Williams DW, Byrd D, Rubin LH, et\u00a0al. CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders. Neurol Neuroimmunol Neuroinflamm. 2014;1(3):e36.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"e_1_3_5_69_1","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1212\/NXI.0000000000000300","article-title":"Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV","volume":"3","author":"Anesten B","year":"2016","unstructured":"Anesten B, Yilmaz A, Hagberg L, et\u00a0al. Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV. Neurol Neuroimmunol Neuroinflamm. 2016;3(6):e300.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"e_1_3_5_70_1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00401-006-0037-0","article-title":"Accelerated tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy","volume":"111","author":"Anthony IC","year":"2006","unstructured":"Anthony IC, Ramage SN, Carnie FW, et\u00a0al. Accelerated tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol. 2006;111(6):529\u2013538.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"e_1_3_5_71_1","doi-asserted-by":"crossref","first-page":"e0169945","DOI":"10.1371\/journal.pone.0169945","article-title":"Neuronal cell death and degeneration through increased nitroxidative stress and tau phosphorylation in HIV-1 transgenic rats","volume":"12","author":"Cho Y-E","year":"2017","unstructured":"Cho Y-E, Lee M-H, Song B-J. Neuronal cell death and degeneration through increased nitroxidative stress and tau phosphorylation in HIV-1 transgenic rats. PLoS One. 2017;12(1):e0169945.","journal-title":"PLoS One"},{"issue":"11","key":"e_1_3_5_72_1","doi-asserted-by":"crossref","first-page":"e77972","DOI":"10.1371\/journal.pone.0077972","article-title":"HIV-1 tat interacts with and regulates the localization and processing of amyloid precursor protein","volume":"8","author":"Kim J","year":"2013","unstructured":"Kim J, Yoon J-H, Kim Y-S. HIV-1 tat interacts with and regulates the localization and processing of amyloid precursor protein. PLoS One. 2013;8(11):e77972.","journal-title":"PLoS One"},{"key":"e_1_3_5_73_1","doi-asserted-by":"crossref","first-page":"4196572","DOI":"10.1155\/2016\/4196572","article-title":"HIV-1 tat regulates occludin and A\u03b2 transfer receptor expression in brain endothelial cells via Rho\/ROCK signaling pathway","volume":"2016","author":"Chen Y","year":"2016","unstructured":"Chen Y, Huang W, Jiang W, et\u00a0al. HIV-1 tat regulates occludin and A\u03b2 transfer receptor expression in brain endothelial cells via Rho\/ROCK signaling pathway. Oxid Med Cell Longev. 2016;2016:4196572\u20134196579.","journal-title":"Oxid Med Cell Longev"},{"key":"e_1_3_5_74_1","doi-asserted-by":"crossref","first-page":"3160360","DOI":"10.1155\/2017\/3160360","article-title":"HIV-1 transactivator protein induces ZO-1 and neprilysin dysfunction in brain endothelial cells via the ras signaling pathway","volume":"2017","author":"Jiang W","year":"2017","unstructured":"Jiang W, Huang W, Chen Y, et\u00a0al. HIV-1 transactivator protein induces ZO-1 and neprilysin dysfunction in brain endothelial cells via the ras signaling pathway. Oxid Med Cell Longev. 2017;2017:3160360.","journal-title":"Oxid Med Cell Longev"},{"issue":"34","key":"e_1_3_5_75_1","doi-asserted-by":"crossref","first-page":"11485","DOI":"10.1523\/JNEUROSCI.0210-14.2014","article-title":"Activation of TRPML1 clears intraneuronal A\u03b2 in preclinical models of HIV infection","volume":"34","author":"Bae M","year":"2014","unstructured":"Bae M, Patel N, Xu H, et\u00a0al. Activation of TRPML1 clears intraneuronal A\u03b2 in preclinical models of HIV infection. J Neurosci. 2014;34(34):11485\u201311503.","journal-title":"J Neurosci"},{"key":"e_1_3_5_76_1","first-page":"3403206","article-title":"Role of cav-1 in HIV-1 Tat-Induced dysfunction of tight junctions and A\u03b2-Transferring Proteins","volume":"2019","author":"Zou M","year":"2019","unstructured":"Zou M, Huang W, Jiang W, et\u00a0al. Role of cav-1 in HIV-1 Tat-Induced dysfunction of tight junctions and A\u03b2-Transferring Proteins. Oxid Med Cell Longev. 2019;2019:3403206\u20133403208.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"e_1_3_5_77_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors","volume":"17","author":"Heaton RK","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, HNRC Group, et\u00a0al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3\u201316.","journal-title":"J Neurovirol"},{"issue":"6","key":"e_1_3_5_78_1","doi-asserted-by":"crossref","first-page":"e98962","DOI":"10.1371\/journal.pone.0098962","article-title":"HIV associated neurocognitive disorders (HAND) in malawian adults and effect on adherence to combination anti-Retroviral therapy: a cross sectional study","volume":"9","author":"Kelly CM","year":"2014","unstructured":"Kelly CM, van Oosterhout JJ, Ngwalo C, et\u00a0al. HIV associated neurocognitive disorders (HAND) in malawian adults and effect on adherence to combination anti-Retroviral therapy: a cross sectional study. PLoS One. 2014;9(6):e98962.","journal-title":"PLoS One"},{"issue":"6","key":"e_1_3_5_79_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11910-008-0073-3","article-title":"HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies","volume":"8","author":"Ances BM","year":"2008","unstructured":"Ances BM, Clifford DB. HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies. Curr Neurol Neurosci Rep. 2008;8(6):455\u2013461.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"e_1_3_5_80_1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s13365-017-0580-6","article-title":"Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study","volume":"23","author":"Kinai E","year":"2017","unstructured":"Kinai E, Komatsu K, Sakamoto M, for HIV-Associated Neurocognitive Disorders in Japanese (J-HAND study group), et\u00a0al. Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study. J Neurovirol. 2017;23(6):864\u2013874.","journal-title":"J Neurovirol"},{"issue":"6","key":"e_1_3_5_81_1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s13365-018-0661-1","article-title":"Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART)","volume":"24","author":"Merlini E","year":"2018","unstructured":"Merlini E, Iannuzzi F, Calcagno A, et\u00a0al. Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART). J Neurovirol. 2018;24(6):679\u2013694.","journal-title":"J Neurovirol"},{"key":"e_1_3_5_82_1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fncel.2018.00307","article-title":"HIV neuroinfection and Alzheimer\u2019s disease: similarities and potential links?","volume":"12","author":"Canet G","year":"2018","unstructured":"Canet G, Dias C, Gabelle A, et\u00a0al. HIV neuroinfection and Alzheimer\u2019s disease: similarities and potential links?. Front Cell Neurosci. 2018;12:307.","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"e_1_3_5_83_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11904-017-0361-0","article-title":"Differentiating HIV-Associated neurocognitive disorders from Alzheimer\u2019s Disease: an Emerging Issue in Geriatric NeuroHIV","volume":"14","author":"Milanini B","year":"2017","unstructured":"Milanini B, Valcour V. Differentiating HIV-Associated neurocognitive disorders from Alzheimer\u2019s Disease: an Emerging Issue in Geriatric NeuroHIV. Curr HIV\/AIDS Rep. 2017;14(4):123\u2013132.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"e_1_3_5_84_1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s13365-018-0695-4","article-title":"Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer\u2019s disease","volume":"25","author":"Pulliam L","year":"2019","unstructured":"Pulliam L, Sun B, Mustapic M, et\u00a0al. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer\u2019s disease. J Neurovirol. 2019;25(5):702\u2013709.","journal-title":"J Neurovirol"},{"issue":"5","key":"e_1_3_5_85_1","doi-asserted-by":"crossref","first-page":"e0155766","DOI":"10.1371\/journal.pone.0155766","article-title":"Identifying neurocognitive decline at 36 months among HIV-Positive participants in the CHARTER cohort using Group-Based trajectory analysis","volume":"11","author":"Brouillette M-J","year":"2016","unstructured":"Brouillette M-J, Yuen T, Fellows LK, et\u00a0al. Identifying neurocognitive decline at 36 months among HIV-Positive participants in the CHARTER cohort using Group-Based trajectory analysis. PLoS ONE. 2016;11(5):e0155766.","journal-title":"PLoS ONE"},{"issue":"4","key":"e_1_3_5_86_1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1212\/WNL.0000000000002277","article-title":"Prevalence of HIV-associated neurocognitive disorders in the multicenter AIDS cohort study","volume":"86","author":"Sacktor N","year":"2016","unstructured":"Sacktor N, Skolasky RL, Seaberg E, et\u00a0al. Prevalence of HIV-associated neurocognitive disorders in the multicenter AIDS cohort study. Neurology. 2016;86(4):334\u2013340.","journal-title":"Neurology"},{"key":"e_1_3_5_87_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12981-015-0063-x","article-title":"The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer\u2019s disease","volume":"12","author":"M\u00e4kitalo S","year":"2015","unstructured":"M\u00e4kitalo S, Mellgren \u00c5, Borgh E, et\u00a0al . The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer\u2019s disease. AIDS Res Ther. 2015;12:23.","journal-title":"AIDS Res Ther"},{"issue":"4","key":"e_1_3_5_88_1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ajoms.2016.01.006","article-title":"Pathogenesis and life cycle of herpes simplex virus infection-stages of primary, latency and recurrence","volume":"28","author":"Kumar SP","year":"2016","unstructured":"Kumar SP, Chandy ML, Shanavas M, et\u00a0al. Pathogenesis and life cycle of herpes simplex virus infection-stages of primary, latency and recurrence. J Oral Maxillofac Surg Med Pathol. 2016;28(4):350\u2013353.","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"issue":"5","key":"e_1_3_5_89_1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2007.06.027","article-title":"Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management","volume":"57","author":"Fatahzadeh M","year":"2007","unstructured":"Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol. 2007;57(5):737\u2013763.","journal-title":"J Am Acad Dermatol"},{"issue":"13","key":"e_1_3_5_90_1","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1134\/S0006297914130124","article-title":"Human herpes simplex virus: life cycle and development of inhibitors","volume":"79","author":"Kukhanova MK","year":"2014","unstructured":"Kukhanova MK, Korovina AN, Kochetkov SN. Human herpes simplex virus: life cycle and development of inhibitors. Biochemistry (Mosc). 2014;79(13):1635\u20131652.","journal-title":"Biochemistry (Mosc)"},{"issue":"9","key":"e_1_3_5_91_1","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1128\/JVI.73.9.7830-7834.1999","article-title":"Three-dimensional structure of herpes simplex virus type 1 glycoprotein D at 2.4-nanometer resolution","volume":"73","author":"Pilling A","year":"1999","unstructured":"Pilling A, Rosenberg MF, Willis SH, et\u00a0al. Three-dimensional structure of herpes simplex virus type 1 glycoprotein D at 2.4-nanometer resolution. J Virol. 1999;73(9):7830\u20137834.","journal-title":"J Virol"},{"issue":"07","key":"e_1_3_5_92_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.9790\/0853-150738591","article-title":"Herpes simplex virus infections, pathophysiology and management","volume":"15","author":"Mustafa M","year":"2016","unstructured":"Mustafa M, Illzam E, Muniandy R, et\u00a0al. Herpes simplex virus infections, pathophysiology and management. IOSR. 2016;15(07):85\u201391.","journal-title":"IOSR"},{"issue":"17","key":"e_1_3_5_93_1","doi-asserted-by":"crossref","first-page":"9624","DOI":"10.1128\/JVI.01350-14","article-title":"The herpes simplex virus 1 virion host shutoff protein enhances translation of viral late mRNAs by preventing mRNA overload","volume":"88","author":"Dauber B","year":"2014","unstructured":"Dauber B, Saffran HA, Smiley JR. The herpes simplex virus 1 virion host shutoff protein enhances translation of viral late mRNAs by preventing mRNA overload. J Virol. 2014;88(17):9624\u20139632.","journal-title":"J Virol"},{"issue":"23","key":"e_1_3_5_94_1","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1128\/JVI.01302-16","article-title":"The splicing history of an mRNA affects its level of translation and sensitivity to cleavage by the virion host shutoff endonuclease during herpes simplex virus infections","volume":"90","author":"Sadek J","year":"2016","unstructured":"Sadek J, Read GS. The splicing history of an mRNA affects its level of translation and sensitivity to cleavage by the virion host shutoff endonuclease during herpes simplex virus infections. J Virol. 2016;90(23):10844\u201310856.","journal-title":"J Virol"},{"issue":"3","key":"e_1_3_5_95_1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/v1030737","article-title":"Activation and evasion of innate antiviral immunity by herpes simplex virus","volume":"1","author":"Melchjorsen J","year":"2009","unstructured":"Melchjorsen J, Matikainen S, Paludan SR. Activation and evasion of innate antiviral immunity by herpes simplex virus. Viruses. 2009;1(3):737\u2013759.","journal-title":"Viruses"},{"issue":"3","key":"e_1_3_5_96_1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1574-6976.2011.00320.x","article-title":"The molecular basis of herpes simplex virus latency","volume":"36","author":"Nicoll MP","year":"2012","unstructured":"Nicoll MP, Proen\u00e7a JT, Efstathiou S. The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev. 2012;36(3):684\u2013705.","journal-title":"FEMS Microbiol Rev"},{"key":"e_1_3_5_97_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fphar.2014.00097","article-title":"HSV-1 and Alzheimer\u2019s disease: more than a hypothesis","volume":"5","author":"Piacentini R","year":"2014","unstructured":"Piacentini R, De Chiara G, Li Puma DD, et\u00a0al . HSV-1 and Alzheimer\u2019s disease: more than a hypothesis. Front Pharmacol. 2014;5:97.","journal-title":"Front Pharmacol"},{"issue":"1","key":"e_1_3_5_98_1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12916-019-1299-4","article-title":"ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease","volume":"17","author":"Safieh M","year":"2019","unstructured":"Safieh M, Korczyn AD, Michaelson DM . ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease. BMC Med. 2019;17(1):64.","journal-title":"BMC Med"},{"issue":"9047","key":"e_1_3_5_99_1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","article-title":"Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease","volume":"349","author":"Itzhaki RF","year":"1997","unstructured":"Itzhaki RF, Lin WR, Shang D, et\u00a0al. Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease. Lancet. 1997;349(9047):241\u2013244.","journal-title":"Lancet"},{"issue":"11","key":"e_1_3_5_100_1","doi-asserted-by":"crossref","first-page":"e13989","DOI":"10.1371\/journal.pone.0013989","article-title":"APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells","volume":"5","author":"De Chiara G","year":"2010","unstructured":"De Chiara G, Marcocci ME, Civitelli L, et\u00a0al. APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS One. 2010;5(11):e13989.","journal-title":"PLoS One"},{"issue":"2","key":"e_1_3_5_101_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2009-0963","article-title":"Alzheimer\u2019s disease-specific tau phosphorylation is induced by herpes simplex virus type 1","volume":"16","author":"Wozniak MA","year":"2009","unstructured":"Wozniak MA, Frost AL, Itzhaki RF. Alzheimer\u2019s disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis. 2009;16(2):341\u2013350.","journal-title":"J Alzheimers Dis"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00324"},{"issue":"1","key":"e_1_3_5_103_1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","article-title":"Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection","volume":"99","author":"Eimer WA","year":"2018","unstructured":"Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, et\u00a0al . Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron. 2018;99(1):56\u201363.e3.","journal-title":"Neuron"},{"key":"e_1_3_5_104_1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fnagi.2016.00242","article-title":"Herpes simplex Virus-Type1 (HSV-1) impairs DNA repair in cortical Neurons","volume":"8","author":"De Chiara G","year":"2016","unstructured":"De Chiara G, Racaniello M, Mollinari C, et\u00a0al. Herpes simplex Virus-Type1 (HSV-1) impairs DNA repair in cortical Neurons. Front Aging Neurosci. 2016;8:242.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"e_1_3_5_105_1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/jnr.23003","article-title":"Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells","volume":"90","author":"Alvarez G","year":"2012","unstructured":"Alvarez G, Aldudo J, Alonso M, et\u00a0al. Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells. J Neurosci Res. 2012;90(5):1020\u20131029.","journal-title":"J Neurosci Res"},{"issue":"5","key":"e_1_3_5_106_1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s13365-015-0344-0","article-title":"Herpes simplex virus type 1 infection in neurons leads to production and nuclear localization of APP intracellular domain (AICD): implications for Alzheimer\u2019s disease pathogenesis","volume":"21","author":"Civitelli L","year":"2015","unstructured":"Civitelli L, Marcocci ME, Celestino I, et\u00a0al . Herpes simplex virus type 1 infection in neurons leads to production and nuclear localization of APP intracellular domain (AICD): implications for Alzheimer\u2019s disease pathogenesis. J Neurovirol. 2015;21(5):480\u2013490.","journal-title":"J Neurovirol"},{"issue":"4","key":"e_1_3_5_107_1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3233\/JAD-150652","article-title":"Protective effect of amyloid-\u03b2 peptides against herpes simplex virus-1 infection in a neuronal cell culture Model","volume":"50","author":"Bourgade K","year":"2016","unstructured":"Bourgade K, Le Page A, Bocti C, et\u00a0al. Protective effect of amyloid-\u03b2 peptides against herpes simplex virus-1 infection in a neuronal cell culture Model. J Alzheimers Dis. 2016;50(4):1227\u20131241.","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"e_1_3_5_108_1","doi-asserted-by":"crossref","first-page":"e1007313","DOI":"10.1371\/journal.ppat.1007313","article-title":"Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent\/quiescent HSV-1 genomes chromatinization through a PML NB\/histone H3.3\/H3.3 chaperone axis","volume":"14","author":"Cohen C","year":"2018","unstructured":"Cohen C, Corpet A, Roubille S, et\u00a0al. Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent\/quiescent HSV-1 genomes chromatinization through a PML NB\/histone H3.3\/H3.3 chaperone axis. PLoS Pathog. 2018;14(9):e1007313.","journal-title":"PLoS Pathog"},{"issue":"9","key":"e_1_3_5_109_1","doi-asserted-by":"crossref","first-page":"e1005834","DOI":"10.1371\/journal.ppat.1005834","article-title":"Latency entry of herpes simplex virus 1 is determined by the interaction of its genome with the nuclear Environment","volume":"12","author":"Maroui MA","year":"2016","unstructured":"Maroui MA, Call\u00e9 A, Cohen C, et\u00a0al. Latency entry of herpes simplex virus 1 is determined by the interaction of its genome with the nuclear Environment. PLoS Pathog. 2016;12(9):e1005834.","journal-title":"PLoS Pathog"},{"issue":"4","key":"e_1_3_5_110_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.1711670403","article-title":"Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type","volume":"167","author":"Jamieson GA","year":"1992","unstructured":"Jamieson GA, Maitland NJ, Wilcock GK, et\u00a0al. Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J Pathol. 1992;167(4):365\u2013368.","journal-title":"J Pathol"},{"issue":"2","key":"e_1_3_5_111_1","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.1042\/bst019122s","article-title":"Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer\u2019s disease brain using polymerase chain reaction","volume":"19","author":"Jamieson GA","year":"1991","unstructured":"Jamieson GA, Maitland NJ, Craske J, et\u00a0al . Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer\u2019s disease brain using polymerase chain reaction. Biochem Soc Trans. 1991;19(2):122S.","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"e_1_3_5_112_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/1673-5374.226380","article-title":"Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology","volume":"13","author":"Hogestyn JM","year":"2018","unstructured":"Hogestyn JM, Mock DJ, Mayer-Proschel M. Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology. Neural Regen Res. 2018;13(2):211\u2013221.","journal-title":"Neural Regen Res"},{"issue":"9136","key":"e_1_3_5_113_1","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(05)70525-0","article-title":"Apolipoprotein E and herpes simplex virus 1 in Alzheimer\u2019s disease","volume":"352","author":"Corder E","year":"1998","unstructured":"Corder E, Lannfelt L, Mulder M. Apolipoprotein E and herpes simplex virus 1 in Alzheimer\u2019s disease. Lancet. 1998;352(9136):1312\u20131313.","journal-title":"Lancet"},{"key":"e_1_3_5_114_1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fnagi.2014.00202","article-title":"Herpes simplex virus type 1 and Alzheimer\u2019s disease: increasing evidence for a major role of the virus","volume":"6","author":"Itzhaki RF","year":"2014","unstructured":"Itzhaki RF . Herpes simplex virus type 1 and Alzheimer\u2019s disease: increasing evidence for a major role of the virus. Front Aging Neurosci. 2014;6:202.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"e_1_3_5_115_1","doi-asserted-by":"crossref","first-page":"594S","DOI":"10.1042\/bst023594s","article-title":"Alzheimer\u2019s disease, herpes simplex virus type 1, cold sores and apolipoprotein E4","volume":"23","author":"Lin W-R","year":"1995","unstructured":"Lin W-R, Shang D, Wilcock GK, et\u00a0al. Alzheimer\u2019s disease, herpes simplex virus type 1, cold sores and apolipoprotein E4. Biochem Soc Trans. 1995;23(4):594S.","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"e_1_3_5_116_1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1538\/expanim.17-0066","article-title":"Establishment of an Alzheimer\u2019s disease model with latent herpesvirus infection using PS2 and Tg2576 double transgenic mice","volume":"67","author":"Tanaka S","year":"2018","unstructured":"Tanaka S, Nagashima H . Establishment of an Alzheimer\u2019s disease model with latent herpesvirus infection using PS2 and Tg2576 double transgenic mice. Exp Anim. 2018;67(2):185\u2013192.","journal-title":"Exp Anim"},{"issue":"3","key":"e_1_3_5_117_1","doi-asserted-by":"crossref","first-page":"e1007617","DOI":"10.1371\/journal.ppat.1007617","article-title":"Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice","volume":"15","author":"De Chiara G","year":"2019","unstructured":"De Chiara G, Piacentini R, Fabiani M, et\u00a0al. Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice. PLoS Pathog. 2019;15(3):e1007617.","journal-title":"PLoS Pathog"},{"issue":"8","key":"e_1_3_5_118_1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tim.2014.04.013","article-title":"Chlamydia genomics: providing novel insights into chlamydial biology","volume":"22","author":"Bachmann NL","year":"2014","unstructured":"Bachmann NL, Polkinghorne A, Timms P. Chlamydia genomics: providing novel insights into chlamydial biology. Trends Microbiol. 2014;22(8):464\u2013472.","journal-title":"Trends Microbiol"},{"issue":"6","key":"e_1_3_5_119_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrmicro.2016.30","article-title":"Chlamydia cell biology and pathogenesis","volume":"14","author":"Elwell C","year":"2016","unstructured":"Elwell C, Mirrashidi K, Engel J. Chlamydia cell biology and pathogenesis. Nat Rev Microbiol. 2016;14(6):385\u2013400.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"e_1_3_5_120_1","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1086\/315596","article-title":"Background and current knowledge of Chlamydia pneumoniae and atherosclerosis","volume":"181","author":"Grayston JT.","year":"2000","unstructured":"Grayston JT. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis. 2000;181(Suppl 3):S402\u2013S410.","journal-title":"J Infect Dis"},{"key":"e_1_3_5_121_1","doi-asserted-by":"crossref","first-page":"273573","DOI":"10.1155\/2010\/273573","article-title":"Chlamydophila pneumoniae infection and its role in neurological disorders","volume":"2010","author":"Contini C","year":"2010","unstructured":"Contini C, Seraceni S, Cultrera R, et\u00a0al. Chlamydophila pneumoniae infection and its role in neurological disorders. Interdiscip Perspect Infect Dis. 2010;2010:273573.","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"e_1_3_5_122_1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fnagi.2018.00302","article-title":"Chlamydia pneumoniae: an etiologic agent for Late-Onset dementia","volume":"10","author":"Balin BJ","year":"2018","unstructured":"Balin BJ, Hammond CJ, Little CS, et\u00a0al. Chlamydia pneumoniae: an etiologic agent for Late-Onset dementia. Front Aging Neurosci. 2018;10:302.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"e_1_3_5_123_1","first-page":"237","article-title":"Chlamydia pneumoniae infection and inflammatory diseases","volume":"7","author":"Porritt RA","year":"2016","unstructured":"Porritt RA, Crother TR. Chlamydia pneumoniae infection and inflammatory diseases. For Immunopathol Dis Therap. 2016;7(3\u20134):237\u2013254.","journal-title":"For Immunopathol Dis Therap"},{"issue":"1","key":"e_1_3_5_124_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrmicro796","article-title":"Chlamydia pneumoniae-an infectious risk factor for atherosclerosis?","volume":"2","author":"Campbell LA","year":"2004","unstructured":"Campbell LA, Kuo C. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis? Nat Rev Microbiol. 2004;2(1):23\u201332.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"e_1_3_5_125_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s004300050071","article-title":"Identification and localization of Chlamydia pneumoniae in the Alzheimer\u2019s brain","volume":"187","author":"Balin BJ","year":"1998","unstructured":"Balin BJ, G\u00e9rard HC, Arking EJ, et\u00a0al. Identification and localization of Chlamydia pneumoniae in the Alzheimer\u2019s brain. Med Microbiol Immunol. 1998;187(1):23\u201342.","journal-title":"Med Microbiol Immunol"},{"key":"e_1_3_5_126_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2202-11-121","article-title":"Immunohistological detection of Chlamydia pneumoniae in the Alzheimer\u2019s disease brain","volume":"11","author":"Hammond CJ","year":"2010","unstructured":"Hammond CJ, Hallock LR, Howanski RJ, et\u00a0al . Immunohistological detection of Chlamydia pneumoniae in the Alzheimer\u2019s disease brain. BMC Neurosci. 2010;11:121.","journal-title":"BMC Neurosci"},{"issue":"5","key":"e_1_3_5_127_1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neurobiolaging.2003.12.021","article-title":"Infiltration of the brain by pathogens causes Alzheimer\u2019s disease","volume":"25","author":"Itzhaki RF","year":"2004","unstructured":"Itzhaki RF, Wozniak MA, Appelt DM, et\u00a0al. Infiltration of the brain by pathogens causes Alzheimer\u2019s disease. Neurobiol Aging. 2004;25(5):619\u2013627.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"e_1_3_5_128_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00430-010-0162-1","article-title":"Chlamydia pneumoniae infection and Alzheimer\u2019s disease: a connection to remember?","volume":"199","author":"Shima K","year":"2010","unstructured":"Shima K, Kuhlenb\u00e4umer G, Rupp J. Chlamydia pneumoniae infection and Alzheimer\u2019s disease: a connection to remember? Med Microbiol Immunol. 2010;199(4):283\u2013289.","journal-title":"Med Microbiol Immunol"},{"issue":"7","key":"e_1_3_5_129_1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1589\/jpts.26.1113","article-title":"Clinical study of respiratory function and difference in pneumonia history between Alzheimer\u2019s Disease and Vascular Dementia Groups","volume":"26","author":"Higashijima M.","year":"2014","unstructured":"Higashijima M. Clinical study of respiratory function and difference in pneumonia history between Alzheimer\u2019s Disease and Vascular Dementia Groups. J Phys Ther Sci. 2014;26(7):1113\u20131114.","journal-title":"J Phys Ther Sci"},{"issue":"3","key":"e_1_3_5_130_1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/07853890.2016.1254349","article-title":"Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer\u2019s disease","volume":"49","author":"Lampela P","year":"2017","unstructured":"Lampela P, Tolppanen A-M, Tanskanen A, et\u00a0al. Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer\u2019s disease. Ann Med. 2017;49(3):230\u2013239.","journal-title":"Ann Med"},{"issue":"5","key":"e_1_3_5_131_1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jnr.10519","article-title":"Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells","volume":"71","author":"MacIntyre A","year":"2003","unstructured":"MacIntyre A, Abramov R, Hammond CJ, et\u00a0al. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J Neurosci Res. 2003;71(5):740\u2013750.","journal-title":"J Neurosci Res"},{"key":"e_1_3_5_132_1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fnagi.2014.00304","article-title":"Detection of bacterial antigens and Alzheimer\u2019s disease-like pathology in the central nervous system of BALB\/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae","volume":"6","author":"Little CS","year":"2014","unstructured":"Little CS, Joyce TA, Hammond CJ, et\u00a0al. Detection of bacterial antigens and Alzheimer\u2019s disease-like pathology in the central nervous system of BALB\/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front Aging Neurosci. 2014;6:304.","journal-title":"Front Aging Neurosci"},{"issue":"37","key":"e_1_3_5_133_1","doi-asserted-by":"crossref","first-page":"39437","DOI":"10.18632\/oncotarget.6254","article-title":"Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer\u2019s disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies","volume":"6","author":"Zelaya MV","year":"2015","unstructured":"Zelaya MV, P\u00e9rez-Valderrama E, de Morentin XM, et\u00a0al. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer\u2019s disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies. Oncotarget. 2015;6(37):39437\u201356.","journal-title":"Oncotarget"},{"issue":"3","key":"e_1_3_5_134_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1574-695X.2006.00154.x","article-title":"Chlamydophila (Chlamydia) pneumoniae in the Alzheimer\u2019s brain","volume":"48","author":"G\u00e9rard HC","year":"2006","unstructured":"G\u00e9rard HC, Dreses-Werringloer U, Wildt KS, et\u00a0al . Chlamydophila (Chlamydia) pneumoniae in the Alzheimer\u2019s brain. FEMS Immunol Med Microbiol. 2006;48(3):355\u2013366.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"e_1_3_5_135_1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0197-4580(03)00127-1","article-title":"Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB\/c mice","volume":"25","author":"Little CS","year":"2004","unstructured":"Little CS, Hammond CJ, MacIntyre A, et\u00a0al. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB\/c mice. Neurobiol Aging. 2004;25(4):419\u2013429.","journal-title":"Neurobiol Aging"},{"key":"e_1_3_5_136_1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12974-014-0217-0","article-title":"Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer\u2019s disease","volume":"11","author":"Lim C","year":"2014","unstructured":"Lim C, Hammond CJ, Hingley ST, et\u00a0al . Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer\u2019s disease. J Neuroinflammation. 2014;11:217.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"e_1_3_5_137_1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12868-019-0489-5","article-title":"Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of \u03b2-amyloid found in Alzheimer disease","volume":"20","author":"Al-Atrache Z","year":"2019","unstructured":"Al-Atrache Z, Lopez DB, Hingley ST, et\u00a0al. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of \u03b2-amyloid found in Alzheimer disease. BMC Neurosci. 2019;20(1):6.","journal-title":"BMC Neurosci"},{"issue":"6","key":"e_1_3_5_138_1","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1371\/journal.ppat.0030083","article-title":"Gene expression profiles of Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated persistence","volume":"3","author":"M\u00e4urer AP","year":"2007","unstructured":"M\u00e4urer AP, Mehlitz A, Mollenkopf HJ, et\u00a0al. Gene expression profiles of Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated persistence. PLoS Pathog. 2007;3(6):e83.","journal-title":"PLoS Pathog"},{"issue":"11","key":"e_1_3_5_139_1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/mp.2013.178","article-title":"An anemia of Alzheimer\u2019s disease","volume":"19","author":"Faux NG","year":"2014","unstructured":"Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B, Masters CL; AIBL Research Group, Bush AI. An anemia of Alzheimer\u2019s disease. Mol Psychiatry. 2014;19(11):1227\u20131234.","journal-title":"Mol Psychiatry"},{"key":"e_1_3_5_140_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mib.2015.09.006","article-title":"Spirochetal motility and chemotaxis in the natural enzootic cycle and development of lyme disease","volume":"28","author":"Motaleb MA","year":"2015","unstructured":"Motaleb MA, Liu J, Wooten RM. Spirochetal motility and chemotaxis in the natural enzootic cycle and development of lyme disease. Curr Opin Microbiol. 2015;28:106\u2013113.","journal-title":"Curr Opin Microbiol"},{"key":"e_1_3_5_141_1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.semcdb.2015.10.015","article-title":"Flagellar motility of the pathogenic spirochetes","volume":"46","author":"Wolgemuth CW.","year":"2015","unstructured":"Wolgemuth CW. Flagellar motility of the pathogenic spirochetes. Semin Cell Dev Biol. 2015;46:104\u2013112.","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"e_1_3_5_142_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/OLQ.0000000000000723","article-title":"Neurosyphilis: knowledge gaps and controversies","volume":"45","author":"Tuddenham S","year":"2018","unstructured":"Tuddenham S, Ghanem KG. Neurosyphilis: knowledge gaps and controversies. Sex Transm Dis. 2018;45(3):147\u2013151.","journal-title":"Sex Transm Dis"},{"issue":"4","key":"e_1_3_5_143_1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1055\/s-0039-1688942","article-title":"Neurosyphilis","volume":"39","author":"Gonzalez H","year":"2019","unstructured":"Gonzalez H, Koralnik IJ, Marra CM. Neurosyphilis. Semin Neurol. 2019;39(4):448\u2013455.","journal-title":"Semin Neurol"},{"key":"e_1_3_5_144_1","first-page":"1","article-title":"Clinical and laboratory characteristics of symptomatic and asymptomatic neurosyphilis in HIV-Negative patients: a retrospective study of 264 cases","volume":"2019","author":"Li W","year":"2019","unstructured":"Li W, Jiang M, Xu D, et\u00a0al. Clinical and laboratory characteristics of symptomatic and asymptomatic neurosyphilis in HIV-Negative patients: a retrospective study of 264 cases. BioMed Res Int. 2019;2019:1\u20136.","journal-title":"BioMed Res Int"},{"issue":"1","key":"e_1_3_5_145_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12879-016-2112-z","article-title":"Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization","volume":"17","author":"Schwenkenbecher P","year":"2017","unstructured":"Schwenkenbecher P, Pul R, Wurster U, et\u00a0al. Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization. BMC Infect Dis. 2017;17(1):90.","journal-title":"BMC Infect Dis"},{"key":"e_1_3_5_146_1","first-page":"6764894","article-title":"A case of undetected neuroborreliosis in a 75-Year-Old chinese Male","volume":"2018","author":"Lamichhane J","year":"2018","unstructured":"Lamichhane J, Haider R, Bekkerman M, et\u00a0al. A case of undetected neuroborreliosis in a 75-Year-Old chinese Male. Case Rep Infect Dis. 2018;2018:6764894.","journal-title":"Case Rep Infect Dis"},{"issue":"4","key":"e_1_3_5_147_1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3233\/JAD-130446","article-title":"Lyme neuroborreliosis and dementia","volume":"41","author":"Blanc F","year":"2014","unstructured":"Blanc F, Philippi N, Cretin B, et\u00a0al. Lyme neuroborreliosis and dementia. J Alzheimers Dis. 2014;41(4):1087\u20131093.","journal-title":"J Alzheimers Dis"},{"issue":"15","key":"e_1_3_5_148_1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00508-018-1361-9","article-title":"Secondary dementia due to lyme neuroborreliosis","volume":"130","author":"Kristoferitsch W","year":"2018","unstructured":"Kristoferitsch W, Aboulenein-Djamshidian F, Jecel J, et\u00a0al. Secondary dementia due to lyme neuroborreliosis. Wien Klin Wochenschr. 2018;130(15\u201316):468\u2013478.","journal-title":"Wien Klin Wochenschr"},{"key":"e_1_3_5_149_1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jns.2016.05.002","article-title":"Dramatic response to a 3-week course of ceftriaxone in late neuroborreliosis mimicking atypical dementia and normal pressure hydrocephalus","volume":"366","author":"Topakian R","year":"2016","unstructured":"Topakian R, Artemian H, Metschitzer B, et\u00a0al. Dramatic response to a 3-week course of ceftriaxone in late neuroborreliosis mimicking atypical dementia and normal pressure hydrocephalus. J Neurol Sci. 2016;366:146\u2013148.","journal-title":"J Neurol Sci"},{"issue":"2","key":"e_1_3_5_150_1","doi-asserted-by":"crossref","DOI":"10.4172\/2314-7326.1000211","article-title":"Alzheimer\u2019s disease: a novel hypothesis for the development and the subsequent role of beta amyloid","volume":"7","author":"Allen HB.","year":"2016","unstructured":"Allen HB. Alzheimer\u2019s disease: a novel hypothesis for the development and the subsequent role of beta amyloid. J Neuroinfect Dis. 2016;7(2):1000211.","journal-title":"J Neuroinfect Dis"},{"key":"e_1_3_5_151_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1742-2094-8-90","article-title":"Alzheimer\u2019s disease - a neurospirochetosis. Analysis of the evidence following Koch\u2019s and Hill\u2019s criteria","volume":"8","author":"Miklossy J","year":"2011","unstructured":"Miklossy J . Alzheimer\u2019s disease - a neurospirochetosis. Analysis of the evidence following Koch\u2019s and Hill\u2019s criteria. J Neuroinflammation. 2011;8:90.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"e_1_3_5_152_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4167\/jbv.2014.44.1.10","article-title":"Insight into the pathogenesis of lyme disease","volume":"44","author":"Shin OS.","year":"2014","unstructured":"Shin OS. Insight into the pathogenesis of lyme disease. J Bacteriol Virol. 2014;44(1):10.","journal-title":"J Bacteriol Virol"},{"key":"e_1_3_5_153_1","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fneur.2018.01048","article-title":"The emerging role of microbial biofilm in lyme Neuroborreliosis","volume":"9","author":"Di Domenico EG","year":"2018","unstructured":"Di Domenico EG, Cavallo I, Bordignon V, et\u00a0al. The emerging role of microbial biofilm in lyme Neuroborreliosis. Front Neurol. 2018;9:1048.","journal-title":"Front Neurol"},{"issue":"11","key":"e_1_3_5_154_1","first-page":"a012427","article-title":"Bacterial quorum sensing: its role in virulence and possibilities for its control","volume":"2","author":"Rutherford ST","year":"2012","unstructured":"Rutherford ST, Bassler BL. Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med 2. 2012;2(11):a012427\u2013a012427.","journal-title":"Cold Spring Harb Perspect Med 2"},{"issue":"1","key":"e_1_3_5_155_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1556\/1886.2015.00049","article-title":"Evidence of in vivo existence of borrelia biofilm in borrelial lymphocytomas","volume":"6","author":"Sapi E","year":"2016","unstructured":"Sapi E, Balasubramanian K, Poruri A, et\u00a0al. Evidence of in vivo existence of borrelia biofilm in borrelial lymphocytomas. Eur J Microbiol Immunol (Bp). 2016;6(1):9\u201324.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"issue":"4","key":"e_1_3_5_156_1","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3233\/JAD-160451","article-title":"Bacterial amyloid and DNA are important constituents of senile plaques: further evidence of the spirochetal and biofilm nature of senile Plaques","volume":"53","author":"Miklossy J.","year":"2016","unstructured":"Miklossy J. Bacterial amyloid and DNA are important constituents of senile plaques: further evidence of the spirochetal and biofilm nature of senile Plaques. J Alzheimers Dis. 2016;53(4):1459\u20131473.","journal-title":"J Alzheimers Dis"},{"key":"e_1_3_5_157_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2377-12-96","article-title":"Neurosyphilis with dementia and bilateral hippocampal atrophy on brain magnetic resonance imaging","volume":"12","author":"Mehrabian S","year":"2012","unstructured":"Mehrabian S, Raycheva M, Traykova M, et\u00a0al. Neurosyphilis with dementia and bilateral hippocampal atrophy on brain magnetic resonance imaging. BMC Neurol. 2012;12:96.","journal-title":"BMC Neurol"},{"key":"e_1_3_5_158_1","doi-asserted-by":"crossref","first-page":"8334","DOI":"10.4076\/1757-1626-2-8334","article-title":"Neurosyphilis presenting with dementia, chronic chorioretinitis and adverse reactions to treatment: a case report","volume":"2","author":"Mehrabian S","year":"2009","unstructured":"Mehrabian S, Raycheva MR, Petrova EP, et\u00a0al. Neurosyphilis presenting with dementia, chronic chorioretinitis and adverse reactions to treatment: a case report. Cases J. 2009;2:8334.","journal-title":"Cases J"},{"issue":"2","key":"e_1_3_5_159_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms","volume":"4","author":"Mayer FL","year":"2013","unstructured":"Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119\u2013128.","journal-title":"Virulence"},{"issue":"1","key":"e_1_3_5_160_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller MA","year":"2007","unstructured":"Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133\u2013163.","journal-title":"Clin Microbiol Rev"},{"key":"e_1_3_5_161_1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.meegid.2013.11.008","article-title":"Molecular epidemiology, phylogeny and evolution of Candida albicans","volume":"21","author":"McManus BA","year":"2014","unstructured":"McManus BA, Coleman DC. Molecular epidemiology, phylogeny and evolution of Candida albicans. Infect Genet Evol. 2014;21:166\u2013178.","journal-title":"Infect Genet Evol"},{"key":"e_1_3_5_162_1","first-page":"41","article-title":"Assessing the advantage of morphological changes in Candida albicans: a game theoretical study","volume":"5","author":"Tyc KM","year":"2014","unstructured":"Tyc KM, K\u00fchn C, Wilson D, et\u00a0al. Assessing the advantage of morphological changes in Candida albicans: a game theoretical study. Front Microbiol. 2014;5:41.","journal-title":"Front Microbiol"},{"issue":"7","key":"e_1_3_5_163_1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tim.2004.05.008","article-title":"The distinct morphogenic states of Candida albicans","volume":"12","author":"Sudbery P","year":"2004","unstructured":"Sudbery P, Gow N, Berman J. The distinct morphogenic states of Candida albicans. Trends Microbiol. 2004;12(7):317\u2013324.","journal-title":"Trends Microbiol"},{"issue":"4","key":"e_1_3_5_164_1","doi-asserted-by":"crossref","first-page":"ftw018","DOI":"10.1093\/femspd\/ftw018","article-title":"Pathogenesis of Candida albicans biofilm","volume":"74","author":"Tsui C","year":"2016","unstructured":"Tsui C, Kong EF, Jabra-Rizk MA. Pathogenesis of Candida albicans biofilm. Pathog Dis. 2016;74(4):ftw018.","journal-title":"Pathog Dis"},{"issue":"5","key":"e_1_3_5_165_1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.7150\/ijbs.11084","article-title":"Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis","volume":"11","author":"Alonso R","year":"2015","unstructured":"Alonso R, Pisa D, Marina AI, et\u00a0al. Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis. Int J Biol Sci. 2015;11(5):546\u2013558.","journal-title":"Int J Biol Sci"},{"key":"e_1_3_5_166_1","doi-asserted-by":"crossref","first-page":"15015","DOI":"10.1038\/srep15015","article-title":"Different brain regions are infected with fungi in Alzheimer\u2019s Disease","volume":"5","author":"Pisa D","year":"2015","unstructured":"Pisa D, Alonso R, R\u00e1bano A, et\u00a0al. Different brain regions are infected with fungi in Alzheimer\u2019s Disease. Sci Rep. 2015;5:15015.","journal-title":"Sci Rep"},{"issue":"7","key":"e_1_3_5_167_1","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/IAI.69.7.4536-4544.2001","article-title":"Traversal of Candida albicans across human blood-brain barrier in vitro","volume":"69","author":"Jong AY","year":"2001","unstructured":"Jong AY, Stins MF, Huang SH, et\u00a0al. Traversal of Candida albicans across human blood-brain barrier in vitro. Infect Immun. 2001;69(7):4536\u20134544.","journal-title":"Infect Immun"},{"issue":"10","key":"e_1_3_5_168_1","doi-asserted-by":"crossref","first-page":"e1002305","DOI":"10.1371\/journal.ppat.1002305","article-title":"Mechanisms of Candida albicans trafficking to the brain","volume":"7","author":"Liu Y","year":"2011","unstructured":"Liu Y, Mittal R, Solis NV, et\u00a0al. Mechanisms of Candida albicans trafficking to the brain. PLoS Pathog. 2011;7(10):e1002305.","journal-title":"PLoS Pathog"},{"issue":"2","key":"e_1_3_5_169_1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jfma.2018.02.005","article-title":"Optimization of fecal sample processing for microbiome study - the journey from bathroom to bench","volume":"118","author":"Wu W-K","year":"2019","unstructured":"Wu W-K, Chen C-C, Panyod S, et\u00a0al . Optimization of fecal sample processing for microbiome study - the journey from bathroom to bench. J Formos Med Assoc. 2019;118(2):545\u2013555.","journal-title":"J Formos Med Assoc"},{"key":"e_1_3_5_170_1","doi-asserted-by":"crossref","first-page":"30028","DOI":"10.1038\/srep30028","article-title":"Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer\u2019s disease","volume":"6","author":"Minter MR","year":"2016","unstructured":"Minter MR, Zhang C, Leone V, et\u00a0al . Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer\u2019s disease. Sci Rep. 2016;6:30028.","journal-title":"Sci Rep"},{"issue":"1","key":"e_1_3_5_171_1","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1038\/s41598-017-11047-w","article-title":"Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE\/PS1\u0394E9 murine model of Alzheimer\u2019s disease","volume":"7","author":"Minter MR","year":"2017","unstructured":"Minter MR, Hinterleitner R, Meisel M, et\u00a0al . Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE\/PS1\u0394E9 murine model of Alzheimer\u2019s disease. Sci Rep. 2017;7(1):10411.","journal-title":"Sci Rep"},{"issue":"1","key":"e_1_3_5_172_1","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1038\/s41598-020-64797-5","article-title":"Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in APPPS1-21 Alzheimer\u2019s transgenic mice","volume":"10","author":"Dodiya HB","year":"2020","unstructured":"Dodiya HB, Frith M, Sidebottom A, et\u00a0al . Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in APPPS1-21 Alzheimer\u2019s transgenic mice. Sci Rep. 2020;10(1):8183.","journal-title":"Sci Rep"},{"issue":"3","key":"e_1_3_5_173_1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1532-5415.2004.52109.x","article-title":"A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer\u2019s disease","volume":"52","author":"Loeb MB","year":"2004","unstructured":"Loeb MB, Molloy DW, Smieja M, et\u00a0al . A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer\u2019s disease. J Am Geriatr Soc. 2004;52(3):381\u2013387.","journal-title":"J Am Geriatr Soc"},{"key":"e_1_3_5_174_1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.06.002","article-title":"Doxycycline counteracts neuroinflammation restoring memory in Alzheimer\u2019s disease mouse models","volume":"70","author":"Balducci C","year":"2018","unstructured":"Balducci C, Santamaria G, La Vitola P, et\u00a0al . Doxycycline counteracts neuroinflammation restoring memory in Alzheimer\u2019s disease mouse models. Neurobiol Aging. 2018;70:128\u2013139.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"e_1_3_5_175_1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2012-120319","article-title":"Enhanced brain amyloid-\u03b2 clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer\u2019s disease","volume":"31","author":"Qosa H","year":"2012","unstructured":"Qosa H, Abuznait AH, Hill RA, et\u00a0al. Enhanced brain amyloid-\u03b2 clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer\u2019s disease. JAD. 2012;31(1):151\u2013165.","journal-title":"JAD"},{"issue":"1","key":"e_1_3_5_176_1","doi-asserted-by":"crossref","first-page":"eaau3333","DOI":"10.1126\/sciadv.aau3333","article-title":"Porphyromonas gingivalis in Alzheimer\u2019s disease brains: evidence for disease causation and treatment with small-molecule inhibitors","volume":"5","author":"Dominy SS","year":"2019","unstructured":"Dominy SS, Lynch C, Ermini F, et\u00a0al . Porphyromonas gingivalis in Alzheimer\u2019s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5(1):eaau3333.","journal-title":"Sci Adv"},{"issue":"6","key":"e_1_3_5_177_1","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s00213-020-05503-1","article-title":"The combination of acyclovir and dexamethasone protects against Alzheimer\u2019s disease-related cognitive impairments in mice","volume":"237","author":"Hui Z","year":"2020","unstructured":"Hui Z, Zhijun Y, Yushan Y, et\u00a0al . The combination of acyclovir and dexamethasone protects against Alzheimer\u2019s disease-related cognitive impairments in mice. Psychopharmacology (Berl). 2020;237(6):1851\u20131860.","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"e_1_3_5_178_1","doi-asserted-by":"crossref","first-page":"e032112","DOI":"10.1136\/bmjopen-2019-032112","article-title":"Antiviral therapy: valacyclovir treatment of Alzheimer\u2019s Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial","volume":"10","author":"Devanand DP","year":"2020","unstructured":"Devanand DP, Andrews H, Kreisl WC, et\u00a0al. Antiviral therapy: valacyclovir treatment of Alzheimer\u2019s Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial. BMJ Open. 2020;10(2):e032112.","journal-title":"BMJ Open"},{"issue":"10","key":"e_1_3_5_179_1","doi-asserted-by":"crossref","first-page":"e25152","DOI":"10.1371\/journal.pone.0025152","article-title":"Antivirals reduce the formation of key Alzheimer\u2019s disease molecules in cell cultures acutely infected with herpes simplex virus type 1","volume":"6","author":"Wozniak MA","year":"2011","unstructured":"Wozniak MA, Frost AL, Preston CM, et\u00a0al. Antivirals reduce the formation of key Alzheimer\u2019s disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLOS One. 2011;6(10):e25152.","journal-title":"PLOS One"},{"issue":"3","key":"e_1_3_5_180_1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.antiviral.2013.07.003","article-title":"The helicase-primase inhibitor Bay 57-1293 reduces the Alzheimer\u2019s disease-related molecules induced by herpes simplex virus type 1","volume":"99","author":"Wozniak MA","year":"2013","unstructured":"Wozniak MA, Frost AL, Itzhaki RF . The helicase-primase inhibitor Bay 57-1293 reduces the Alzheimer\u2019s disease-related molecules induced by herpes simplex virus type 1. Antiviral Res. 2013;99(3):401\u2013404.","journal-title":"Antiviral Res"},{"issue":"2","key":"e_1_3_5_181_1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5946\/ce.2019.009","article-title":"Fecal microbiota transplantation: an update on clinical Practice","volume":"52","author":"Kim KO","year":"2019","unstructured":"Kim KO, Gluck M. Fecal microbiota transplantation: an update on clinical Practice. Clin Endosc. 2019;52(2):137\u2013143.","journal-title":"Clin Endosc"},{"issue":"1","key":"e_1_3_5_182_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40168-017-0269-3","article-title":"Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease","volume":"5","author":"Khanna S","year":"2017","unstructured":"Khanna S, Vazquez-Baeza Y, Gonz\u00e1lez A, et\u00a0al. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease. Microbiome. 2017;5(1):55.","journal-title":"Microbiome"},{"key":"e_1_3_5_183_1","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2147\/IDR.S308308","article-title":"Fecal microbiota transplantation as an effective treatment for Carbapenem-Resistant Klebsiella pneumoniae infection in a renal transplant Patient","volume":"14","author":"Wang J","year":"2021","unstructured":"Wang J, Li X, Wu X, et\u00a0al. Fecal microbiota transplantation as an effective treatment for Carbapenem-Resistant Klebsiella pneumoniae infection in a renal transplant Patient. Infect Drug Resist. 2021;14:1805\u20131811.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"e_1_3_5_184_1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000507263","article-title":"Fecal microbiota transplant in a patient infected with Multidrug-Resistant bacteria: a case Report","volume":"28","author":"Gouveia C","year":"2020","unstructured":"Gouveia C, Palos C, Pereira P, et\u00a0al. Fecal microbiota transplant in a patient infected with Multidrug-Resistant bacteria: a case Report. GE Port J Gastroenterol. 2020;28(1):56\u201361.","journal-title":"GE Port J Gastroenterol"},{"key":"e_1_3_5_185_1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fcimb.2020.00098","article-title":"Fecal microbiota transplantation in neurological disorders","volume":"10","author":"Vendrik KEW","year":"2020","unstructured":"Vendrik KEW, Ooijevaar RE, de Jong PRC, et\u00a0al. Fecal microbiota transplantation in neurological disorders. Front Cell Infect Microbiol. 2020;10:98.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"e_1_3_5_186_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","article-title":"Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study","volume":"5","author":"Kang D-W","year":"2017","unstructured":"Kang D-W, Adams JB, Gregory AC, et\u00a0al. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017;5(1):10.","journal-title":"Microbiome"},{"issue":"1","key":"e_1_3_5_187_1","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1038\/s41598-019-42183-0","article-title":"Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota","volume":"9","author":"Kang D-W","year":"2019","unstructured":"Kang D-W, Adams JB, Coleman DM, et\u00a0al. Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota. Sci Rep. 2019;9(1):5821.","journal-title":"Sci Rep"},{"issue":"1","key":"e_1_3_5_188_1","first-page":"13","article-title":"Fecal microbiota transplantation alleviated Alzheimer\u2019s disease-like pathogenesis in APP\/PS1 transgenic mice","volume":"9","author":"Sun J","year":"2019","unstructured":"Sun J, Xu J, Ling Y, et\u00a0al. Fecal microbiota transplantation alleviated Alzheimer\u2019s disease-like pathogenesis in APP\/PS1 transgenic mice. Transl Psychiatry. 2019;9(1):13.","journal-title":"Transl Psychiatry"},{"issue":"6","key":"e_1_3_5_189_1","doi-asserted-by":"crossref","first-page":"300060520925930","DOI":"10.1177\/0300060520925930","article-title":"Rapid improvement in Alzheimer\u2019s disease symptoms following fecal microbiota transplantation: a case report","volume":"48","author":"Hazan S","year":"2020","unstructured":"Hazan S . Rapid improvement in Alzheimer\u2019s disease symptoms following fecal microbiota transplantation: a case report. J Int Med Res. 2020;48(6):300060520925930.","journal-title":"J Int Med Res"}],"container-title":["International Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00207454.2022.2045290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T18:17:13Z","timestamp":1695925033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00207454.2022.2045290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":188,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10,3]]}},"alternative-id":["10.1080\/00207454.2022.2045290"],"URL":"https:\/\/doi.org\/10.1080\/00207454.2022.2045290","relation":{},"ISSN":["0020-7454","1543-5245"],"issn-type":[{"value":"0020-7454","type":"print"},{"value":"1543-5245","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ines20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ines20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-09-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}